MedeAnalytics Leadership Team
MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes.
Mike Gallagher has over 30 years experience in healthcare executive leadership, with demonstrated success in management, operations, strategic planning, financial controls, acquisitions and divestitures. Mike assumed the role as the company's executive chairman in May 2013 after serving as its chairman and chief executive officer since 2009. Mike started serving on the MedeAnalytics board of directors in 2004. He served as vice chairman from 2006-2009.
Prior to becoming MedeAnalytics' chief executive officer in 2007, Mike served as a partner in Shamrock Investments, LLC, a firm he co-founded in 1987. He has been an investor and advisor in numerous merger and acquisition and strategic planning engagements, and has served on the boards of several public and private providers and health plan organizations. Mike currently serves on the governing boards of USC University Hospital and USC Norris Cancer Hospital. He was formerly chairman, president and chief executive officer of Health Net of California, chief executive officer of Paragon Ambulatory Surgery and a group vice president with American Medical International. Mike's professional career also included positions with Coopers & Lybrand and service in the United States Marine Corps.
Mike holds a bachelor's degree in economics and a master of business administration from the University of Southern California.
Andy Hurd joined MedeAnalytics in May 2013 as chief executive officer, bringing with him over 25 years of experience in healthcare IT, including product and market innovation as well as strategic partnerships.
Most recently, Andy was CEO of Epocrates (NASDAQ: EPOC), which was purchased by athenahealth (NASDAQ: ATHN). Prior to Epocrates, Andy served as chairman and CEO of Carefx, which was acquired by Harris Corporation (NYSE: HRS) in 2011. During his six-year tenure at Carefx, the company achieved strong growth in revenue, income and shareholder value. Before Carefx, Hurd held senior management positions at WebMD, LLC (NASDAQ: WBMD) and QuadraMed Corporation.
Andy holds a bachelor's degree in business administration from Northern Arizona University, and he is a member of the board of directors of Ability Networks and the Cleveland Clinic Innovations Advisory Board.
Sal DeTrane joined MedeAnalytics in 2004 and is responsible for finance, human resources, and a variety of key operating initiatives, as well as the company’s growth strategy and business development initiatives, which include channel and partnership development, and merger and acquisition activities. Prior to joining MedeAnalytics, Sal was a founding managing director of Nucleus Partners LLC, a venture capital and consulting business. While at Nucleus, Sal supported the MedeAnalytics' board for 18 months in developing and executing the company’s business strategy and realizing the successful syndication of a Series B funding round. Sal also led the company’s Series C financing in 2008.
Prior to Nucleus Partners, Sal had significant roles in managing The Halo Fund, a $25 million venture fund that co-invested with The Angels' Forum, an angel organization with a $20 million private equity portfolio. While at Nucleus Partners and The Angels' Forum, he was an active advisor and participant on many of the boards of directors of early and growth-stage portfolio companies. Prior to that, Sal was a director in Andersen’s Technology Corporate Finance practice, where he advised and assisted clients on acquisition, divestiture, joint venture and private equity transactions in a broad range of technology and healthcare segments. Sal has a bachelor's degree in business administration from Temple University and is a certified public accountant. Sal relaxes shooting hoops and coaching his son’s sports teams, and he is a newbie in the world of winemaking.
Dr. Fouts joined MedeAnalytics in September 2008 as chief medical officer with a leadership role guiding the strategic development of MedeAnalytics' clinical products and services. He served for 19 years as a medical executive for healthcare providers and major health plans, including Health Net, Great-West Healthcare, Aetna and Cigna, developing policy, wellness and disease management programs, and quality initiatives, as well guiding product development. He has been responsible for managing national and international programs to reduce medical costs and strengthen health operations. Dr. Fouts' medical executive career follows a 19-year career as a practicing internist.
Steve Lerch joined MedeAnalytics in June 2009 and served as the company’s chief financial officer from 2009-2012 before his appointment to his current position. With over 30 years in business, management and public accounting, Steve brings a unique blend of broad industry skills, significant transaction experience and an extensive public company finance and operating background to the company.
Most recently, Steve served as the chief revenue officer for Kowabunga! Inc. (AMEX: KOW), a leader in performance marketing and technology solutions for the online advertising industry. Prior to that, Steve spent 11 years serving as the chief financial officer and chief operating officer for Workstream, Inc. (NASDAQ: WSTM), an on-demand software company in the talent management space, and Rewards Network, Inc. (NASDAQ: DINE), a credit card-based loyalty marketing and finance platform. Prior to his various executive suite roles, Steve was a business assurance partner for Coopers & Lybrand LLP, now PricewaterhouseCoopers, where his client base included numerous healthcare institutions.
Steve and wife Renee have four children ranging in age from 19 to 27. Steve is an avid sports fan and golfer and is also very active in various parish ministries. He is a history buff and enjoys reading. Steve holds a bachelor’s degree in accounting from the University of Notre Dame.
Anthony McKeever has over 35 years of proven leadership experience across the NHS. Mac is responsible for continuing the company's growth and expanding our products for the UK market.
Most recently, McKeever was the chief executive of Bexley Care Trust where he helped GPs transform local performance, establishing Bexley as a leading Pathfinder whose achievements were recognised in three prestigious Health Service Journal awards, including the Secretary of State's award for excellence in healthcare management. Mac started his career with the Department of Health and progressed with many executive level positions at high profile facilities that include Mersey Regional Health Authority, Royal Shrewsbury Hospital and Surrey & Sussex Healthcare.
Mac was appointed to the NHS Future Forum in 2011, which conducted a "listening exercise" on behalf of the government and produced two reports on aspects of the proposed healthcare reforms.
Scott Paddock joined MedeAnalytics in July 2008 with more than 15 years experience in operations, mergers and acquisitions, corporate sales and marketing, with an emphasis in healthcare and a history of achievement in leading revenue expansion. Scott oversees all U.S. sales.
Most recently, he served as executive vice president and chief solutions officer at MEDecision, Inc. Prior to MEDecision, Paddock was senior vice president of the Applied Technologies Solutions Division of RWD Technologies and spent over seven years in the health care and technology sectors of General Electric (GE) Corporation in various leadership, marketing and sales positions.
Scott is a trained Six Sigma Black Belt and holds a master's degree from Franklin University of Ohio. He earned bachelor's degrees in mechanical engineering and physics from the State University of New York at Buffalo and Fredonia, respectively.
Scott is a member of HIMSS and the American College of Healthcare Executives.
Ken Perez joined MedeAnalytics in February 2009 with over 20 years of experience in business, serving in senior marketing, business development and finance roles for technology and healthcare IT companies. Ken leads the strategic direction and orchestration of all of MedeAnalytics' marketing functions, including product marketing, marketing communications and healthcare policy activities.
Previous to MedeAnalytics, Ken was a senior partner in a highly successful boutique sales and marketing consulting firm and was president of a California-based, international nonprofit organization. Ken served for seven and a half years as the vice president of marketing for Omnicell, Inc. (NASDAQ: OMCL), a healthcare IT company he helped take public in August 2001, writing the company's S-1, shaping road show messaging and sharing responsibility for investor relations with the company's CFO. Omnicell's market capitalization increased during Ken's tenure from $150 million at the IPO to over $600 million. Additionally, Ken spent 11 years with Hewlett-Packard Company, serving in a variety of financial management and business development positions.
Ken earned his bachelor's degree in international relations from Stanford University and a master's degree in finance from UCLA. Ken is an avid skier and has enjoyed coaching youth basketball teams. He and his wife Janet have three teenage children.
Elizabeth Rushforth joined MedeAnalytics in April 2013 with more than 15 years of legal experience, with an emphasis on corporate, securities, compliance and governance. Most recently, she served as general counsel, corporate secretary and chief compliance officer for Unwired Planet, Inc. (formerly Openwave Systems Inc.). Elizabeth also served as Unwired Planet’s associate general counsel from 2009 to 2011 and as interim general counsel from 2008 to 2009.
Prior to joining Openwave Systems, Elizabeth worked as corporate counsel at Sunrise Telecom Incorporated, a telecom management solutions provider.
Elizabeth holds a J.D. from the Washington University School of Law and a B.S. in management from California State Polytechnic University, Pomona. She is a member of the California, Missouri and Texas state bars.
Elizabeth, her husband Jim, and their Labrador Blizzard enjoy life in the Lake Tahoe area where they spend their time skiing, snowboarding, hiking, and kayaking.
Ping Zhang joined MedeAnalytics in April 2013 with over 20 years of technology, product innovation, client delivery, and business experience. He has provided engineering leadership for a wide variety of organizations, ranging from startups to some of the world’s best-known technology companies. Most recently, Ping was the senior vice president of research & development at Epocrates, Inc., a mobile and cloud-based health pioneer widely recognized for developing the most popular point-of-care medical applications used by physicians. Prior to Epocrates, he held executive leadership positions for Harris Corporation, Carefx Corporation, QuadraMed Corporation, and Siemens.
Ping earned his bachelor’s degree at the age of 19 from Hunan Agricultural University in Changsha, China. He holds both a Master of Science degree and a Ph.D. degree from the University of Arkansas at Fayetteville.
Ping enjoys reading, jogging, and playing basketball with his two teenage boys. He also serves as a volunteer judge for youth speech and debate events.
"MedeAnalytics' advanced analytics and their short implementation schedule gave us a kick start to the value that the MedeAnalytics application provides."
- Terry Conrad
Chief Financial Officer
St. Vincent Health System
"POET [Blue Shield of California’s name for MedeAnalytics’ Operational Transparency solution] represents a smarter way of doing business. Since hospital contracting executives can now see all the data sharing and collaborative work that happens, we no longer have as much finger-pointing over claims disputes."
- Juan Davila
SVP, Network Management
Blue Shield of California
"When we first researched analytics solutions and their capabilities, MedeAnalytics was the obvious choice. There’s just no comparison."
- Michelle Jones
Director of Patient Financial Services
Wheaton Franciscan Healthcare
"MedeAnalytics is the one solution that enables us to balance the constant challenges of providing quality patient care while managing our bottom-line."
- Domenic Segalla
Chief Financial Officer
Newark Beth Israel Medical Center
"MedeAnalytics enables us to identify and quickly focus efforts to collaboratively improve medical management by screening trends in cost drivers and performing drill downs to identify and address root causes."
- Meredith Mathews, M.D.
SVP and CMO Blue Shield of California
"The MedeAnalytics solution allowed our team to quickly implement work lists which have resulted in improved cash collections. We are confident that with MedeAnalytics' analytics we will continue to see improvements in our revenue cycle and registration areas."
- Julie Carpenter
Administrative Director of Revenue Cycle
St. Vincent Health System
"I am extremely impressed and pleased with MedeAnalytics' smooth implementation and the fact we are live and operational within 45 days of signing the contract agreement."
- Terry Conrad
Chief Financial Officer
St. Vincent Health System
"One of the greatest impacts has been the use of a single platform of information for individuals, teams, management and across departments that has created a collaborative effort in managing the revenue cycle."
- Kelly Turner
Chief Financial Officer
Glendale Adventist Medical Center
"MedeAnalytics has had the great foresight of being able to see that this vision of clinical and financial measurement was going to occur…and is now very well positioned to succeed in healthcare in the decade ahead."
- James B. Couch, M.D., J.D. FACPE
Managing Partner and Chief Medical Officer
Patient Safety Solutions, LLC
"The MedeAnalytics compliance solution provides desktop analysis of inpatient and outpatient data, utilizing actual claims data submitted to payers. The potential for useful compliance queries is unlimited and will continue to help with our RAC and other compliance risk assessments in the future."
- Patricia Puckett
Director of Compliance
West Tennessee Healthcare
"MedeAnalytics' software as a service analytics platform provides our health system the ability to better manage our revenue cycle with readily available, enterprise-wide financial data."
- Gary J. Borgstede
System Vice President of Finance
Oschner Health System
"MedeAnalytics helps us identify emerging trends and issues impacting our membership and network providers. The solutions support the Alliance in managing member care and provide us with the ability to adapt and change in the future as our membership grows."
- Ingrid Lamirault
Chief Executive Officer
Alameda Alliance for Health
"MedeAnalytics has a proven track record with BHS. The analytics solutions and added value of MedeAnalytics' experienced client team quickly helped me reach my initial goal of reducing AR days. In addition we've reduced bad debt and improved our clean claim rate. Since implementation the return with MedeAnalytics has been swift and sustainable. I look forward to the same success in improving our reserve process across the BHS facilities."
- Janice Ridling
VP, Revenue Management
Baptist Health System
"BancorpSouth Insurance selected MedeAnalytics as a partner to utilize its web-based interactive reporting solution to enhance our client experience and improve employee benefit plan performance. The drill-down capabilities and overall solutions will help our employee benefit consultants better analyze and identify their clients’ medical and pharmacy expenses to improve both cost and quality."
- Ginger Campbell
VP, Health Benefit Analytics and Pharmacy Consulting
"The customer service we receive is just superb. They aren’t just selling a solution. They are selling a solution with service."
- Jon Giese
Chief Financial Officer
Simi Valley Hospital, Adventist Health